NewAmsterdam Pharma reports positive data in Phase II dyslipidemia trial
In the trial, treatment with 5mg and 10mg obicetrapib respectively led to a 42% and 51% decline in LDL-c.
Netherlands
Latest in
Netherlands
Triall enters partnership to anchor Covid-19 data to blockchain
Triall will leverage LTO Network's blockchain technology and infrastructure to anchor the research data.
Akston initiates subject dosing in Phase II Covid-19 vaccine trial
Being carried out at University Medical Center Groningen in the Netherlands, the trial will have 52 participants.
argenx reports positive data of efgartigimod in myasthenia gravis trial
The Phase III trial met the primary endpoint with efgartigimod showing improvement in the quality of life of patients.
AIM ImmunoTech initiates dosing in intranasal Covid-19 drug study
AIM ImmunoTech has dosed the first healthy participants in a Phase I clinical study of its Ampligen drug as a…
AIM ImmunoTech to commence study of intranasal Covid-19 therapy
AIM ImmunoTech is set to commence the Phase I clinical study of its Ampligen drug as an intranasal therapy for…
InteRNA Technologies begins dosing in solid tumour drug trial
InteRNA Technologies has dosed the first patient in the first cohort of its first-in-human Phase I study of its lead…
AstraZeneca’s Farxiga prolongs survival in chronic kidney disease trial
AstraZeneca has reported positive data from a subgroup analysis from Phase III DAPA-CKD trial of Farxiga (dapagliflozin) in patients with…